Fabiana Quaglia Selected Research

UCON 50-HB-5100 (F127)

2/2017	Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells.
9/2016	Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.
1/2016	Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabiana Quaglia Research Topics

Disease

24	Neoplasms (Cancer) 10/2022 - 09/2004
6	Cystic Fibrosis (Mucoviscidosis) 02/2022 - 04/2011
6	Lung Diseases (Lung Disease) 02/2022 - 01/2012
5	Pneumonia (Pneumonitis) 01/2022 - 04/2011
5	Inflammation (Inflammations) 01/2022 - 06/2005
5	Infections 01/2020 - 08/2015
2	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 07/2021 - 09/2016
2	Wounds and Injuries (Trauma) 01/2021 - 01/2018
2	Triple Negative Breast Neoplasms 09/2019 - 10/2014
2	Neoplasm Metastasis (Metastasis) 12/2018 - 10/2018
2	Hemorrhage 01/2018 - 11/2012
1	COVID-19 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Communicable Diseases (Infectious Diseases) 10/2020
1	Eye Infections 07/2019
1	Mouth Diseases (Mouth Disease) 10/2017
1	Phototoxic Dermatitis (Phototoxicity) 02/2017
1	Colonic Neoplasms (Colon Cancer) 11/2016

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 09/2019 - 09/2004
10	Docetaxel (Taxotere)FDA Link 10/2022 - 07/2012
4	Biological ProductsIBA 03/2022 - 02/2014
4	PolymersIBA 02/2022 - 03/2015
4	Small Interfering RNA (siRNA)IBA 02/2022 - 01/2018
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 01/2016
4	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 03/2015
4	MicellesIBA 02/2017 - 12/2010
4	OligonucleotidesIBA 01/2016 - 07/2009
3	UCON 50-HB-5100 (F127)IBA 02/2017 - 01/2016
2	LigandsIBA 10/2022 - 05/2016
2	AminesIBA 12/2018 - 10/2018
2	LipopolysaccharidesIBA 09/2018 - 04/2011
2	AnticoagulantsIBA 01/2018 - 11/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 05/2016
2	Poloxamer (Poloxamer 407)IBA 02/2017 - 09/2016
2	Verteporfin (Visudyne)FDA Link 02/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 11/2016 - 04/2011
2	Niclosamide FDA Link 09/2016 - 08/2015
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2016 - 09/2004
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2016 - 04/2011
2	PorphyrinsIBA 03/2015 - 08/2011
2	polycaprolactoneIBA 10/2014 - 10/2002
2	CyclodextrinsIBA 10/2014 - 08/2011
2	NF-kappa B (NF-kB)IBA 07/2009 - 06/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	LipidsIBA 02/2022
1	GelsIBA 01/2022
1	Hand SanitizersIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	EmulsionsIBA 07/2021
1	DisulfidesIBA 07/2021
1	LuciferasesIBA 07/2021
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 07/2021
1	TubulinIBA 07/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	ChlorineIBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 01/2020
1	Piperacillin FDA LinkGeneric 01/2020
1	Polyglactin 910IBA 01/2019
1	Antimicrobial PeptidesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Drug CarriersIBA 10/2018
1	chlorinIBA 10/2018
1	AlginatesIBA 01/2018
1	Tranexamic Acid (AMCA)FDA Link 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017
1	pluronic block copolymer P123IBA 02/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2016
1	Fluorouracil (Carac)FDA LinkGeneric 11/2016
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 10/2016
1	Antimitotic AgentsIBA 10/2016
1	Biotin (Vitamin H)FDA Link 09/2016
1	Cisplatin (Platino)FDA LinkGeneric 09/2016
1	6- astatomethyl- 19- norcholest- 5(10)- en- 3- olIBA 09/2016
1	aziridine (ethyleneimine)IBA 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Antimicrobial Cationic PeptidesIBA 11/2015
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 04/2015
1	PolyethyleneimineIBA 04/2015
1	Drug CombinationsIBA 03/2015
1	PowdersIBA 10/2014
1	VaccinesIBA 10/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2013
1	AcidsIBA 11/2012
1	polyethylene oxide-polycaprolactone copolymerIBA 07/2012
1	MucinsIBA 01/2012
1	OligodeoxyribonucleotidesIBA 04/2011
1	Interleukin-8 (Interleukin 8)IBA 04/2011

Therapy/Procedure

15	Therapeutics 02/2022 - 01/2009
7	Drug Therapy (Chemotherapy) 10/2022 - 09/2004
5	Photochemotherapy (Photodynamic Therapy) 01/2020 - 01/2016
1	Contact Lenses 07/2019
1	Oral Surgical Procedures 01/2018
1	Precision Medicine 02/2017
1	Intravenous Injections 02/2014
1	Immunotherapy 10/2013
1	Oral Surgery (Maxillofacial Surgery) 11/2012